GHDx
Published on GHDx (https://ghdx.healthdata.org)


Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib?

General Info

Geography 
Netherlands (NLD)
Time period covered 
January, 2001 - December, 2005
Data type
Scientific literature
Keywords 
Chemotherapy, Health care costs, Multiple myeloma

Citation

Authors 
Franken MG, Gaultney JG, Blommestein HM, Huijgens PC, Sonneveld P, Redekop WK, Uyl-de Groot CA
Journal 
Value Health
Pages 
245-53
Publication year 
2014
Suggested citation 
Franken MG, Gaultney JG, Blommestein HM, Huijgens PC, Sonneveld P, Redekop WK, Uyl-de Groot CA. Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib?. Value Health. 2014; 17(2): 245-53.

Source URL:https://ghdx.healthdata.org/record/policymaker-please-consider-your-needs-carefully-does-outcomes-research-relapsed-or#comment-0